title: Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry.
authors.affiliation: Department of Rheumatology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark.
authors.forename: L
authors.initials: L
authors.lastname: Dreyer
authors.affiliation: The Danish Multiple Sclerosis Registry, Neuroscience Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Department of Neurology, The Danish Multiple Sclerosis Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
authors.forename: M
authors.initials: M
authors.lastname: Magyari
authors.affiliation: National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
authors.forename: B
authors.initials: B
authors.lastname: Laursen
authors.affiliation: Department of Rheumatology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark.
authors.forename: R
authors.initials: R
authors.lastname: Cordtz
authors.affiliation: Department of Neurology, The Danish Multiple Sclerosis Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
authors.forename: F
authors.initials: F
authors.lastname: Sellebjerg
authors.affiliation: Department of Rheumatology, Frederiksberg Hospital, Frederiksberg, Denmark.
authors.forename: H
authors.initials: H
authors.lastname: Locht
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003718:Denmark / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000453:epidemiology*; D012042:Registries; D012307:Risk Factors; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha
keywords: Ankylosing Spondylitis; Anti-TNF; Rheumatoid Arthritis